1
|
Kahn M, Irwin C, Pillion M, Whittall H, Fitton J, Sprajcer M, Gradisar M. Sleepless on the road: Are mothers of infants with insomnia at risk for impaired driving? J Sleep Res 2024; 33:e14083. [PMID: 37904304 DOI: 10.1111/jsr.14083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Revised: 08/18/2023] [Accepted: 10/13/2023] [Indexed: 11/01/2023]
Abstract
Infant sleep problems have been associated with a myriad of adverse child and parent outcomes, yet whether these problems may pose a risk for parents on the road has received little research attention. This study sought to test whether mothers of infants with insomnia are at an elevated risk for vehicular crashes, by comparing their objectively measured driving performance with that of mothers of well-sleeping infants and with that of women without children. Fifty-four women from these three groups completed a simulated driving task. Outcome measures included standard deviation of lateral position, number of lane crossings, standard deviation of speed, average speed and maximum speed. Women additionally reported on their driving behaviour using the Driving Behaviour Questionnaire, and on sleep, sleepiness and insomnia symptoms using 7-day sleep diaries and questionnaires. Mothers of infants with insomnia demonstrated greater lane deviation (Wald = 9.53, p = 0.009), higher maximum speed (Wald = 6.10, p = 0.04) and poorer self-rated driving behaviour (Wald = 7.44, p = 0.02) compared with control groups. Analyses also indicated that driving performance in mothers of infants with insomnia tended to be poorer relative to control groups with the progression of time on task. While further research is needed to assess the scope of these effects, our findings suggest that parents, healthcare providers and policymakers should be aware of the potential consequences of infant sleep problems on road safety, and collaborate to establish strategies to mitigate these risks.
Collapse
Affiliation(s)
- Michal Kahn
- School of Psychological Sciences, Tel Aviv University, Tel Aviv, Israel
- Flinders University, College of Education, Psychology and Social Work, Adelaide, Australia
| | - Christopher Irwin
- Menzies Health Institute Queensland and School of Health Sciences and Social Work, Griffith University, Gold Coast, Australia
| | - Meg Pillion
- Flinders University, College of Education, Psychology and Social Work, Adelaide, Australia
| | - Hannah Whittall
- Flinders University, College of Education, Psychology and Social Work, Adelaide, Australia
| | - Josh Fitton
- Flinders University, College of Education, Psychology and Social Work, Adelaide, Australia
| | - Madeline Sprajcer
- Appleton Institute, Central Queensland University, Adelaide, Australia
| | - Michael Gradisar
- Wink Sleep Pty Ltd, Adelaide, Australia
- Sleep Cycle AB, Gothenburg, Sweden
| |
Collapse
|
2
|
Irwin C, McCartney D, Grant G, Delang N, Bartrim K, Cox GR, Desbrow B. Effects of Different Sources of Low-Dose Caffeine on Mood/Arousal and Cognitive Performance. Percept Mot Skills 2022; 129:1672-1690. [PMID: 36040101 DOI: 10.1177/00315125221124369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In this study we investigated the effects of variously derived sources of low-dose caffeine on mood/arousal and cognitive performance. Twenty-two participants (15 men, 7 women; M age: 28.2, SD = 9.0 years) undertook five randomized, crossover trials in which they consumed either a water control (CON) or 80 mg of caffeine from one of four sources (coffee [COF], energy drink [END], capsule [CAP], and dissolvable mouth strip [STR]). We measured the participants' perceived efficacy of these varied caffeine sources pre-treatment; and we measured mood/arousal at pre-treatment, and again at 15 and 45 minutes post-treatment. We also measured choice reaction-time at 15 and 45 minutes post-treatment, and participants completed the psychomotor vigilance task (PVT) 45 minutes post-treatment. Caffeine increased participant ratings of alertness and decreased their ratings of tiredness irrespective of source (p's < .05), and all sources of caffeine decreased reaction time on the PVT (p's < .05), with ex-Gaussian distributional analysis localizing this to the tau-parameter, indicating lower variability. However, only the COF source was associated with improved 'overall mood' (p's < .05). Participants expected to perform better on the PVT with COF compared to CON, but there were no other significant associations between source expectancy and performance. In sum, a modest dose of caffeine, regardless of source, positively impacted mood/arousal and cognitive performance, and these effects did not appear to be influenced by expectations.
Collapse
Affiliation(s)
- Christopher Irwin
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia.,Menzies Health Institute Queensland, Australia
| | - Danielle McCartney
- School of Psychology, Faculty of Science, 4334University of Sydney, Sydney, NSW, Australia
| | - Gary Grant
- School of Pharmacy and Medical Sciences, 97562Griffith University, Gold Coast, QLD, Australia
| | - Nathan Delang
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia
| | - Karly Bartrim
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia
| | - Gregory R Cox
- Faculty of Health Sciences and Medicine, 3555Bond University, Robina, QLD, Australia
| | - Ben Desbrow
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia.,Menzies Health Institute Queensland, Australia
| |
Collapse
|
3
|
The Matrix Matters: Beverage Carbonation Impacts the Timing of Caffeine Effects on Sustained Attention. Nutrients 2022; 14:nu14112305. [PMID: 35684105 PMCID: PMC9183000 DOI: 10.3390/nu14112305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 05/17/2022] [Accepted: 05/20/2022] [Indexed: 12/04/2022] Open
Abstract
Both caffeine and the perception of refreshment delivered by cooling, tingling, and mouth-watering flavors have individually been shown to positively impact cognitive performance and mood, though presently there is limited evidence on their possible combined effects. This study explored the contribution of refreshing compounds in beverages, namely, carbon dioxide and citric acid, on the acute effects of caffeine on sustained attention and self-rated physical and mental energy. A randomized, controlled crossover trial was conducted by testing three products: a carbonated caffeinated beverage; a comparator caffeinated beverage; and a flavor-matched control beverage. Findings from 24 healthy adults revealed product-dependent variations in cognitive performance during a 60-min visual sustained-attention task, suggesting that the carbonated-caffeinated beverage led to faster, greater and more consistent levels of accuracy, compared to the control beverage. Specifically, significant differences were found between: (1) the carbonated-caffeinated beverage and the caffeinated beverage, and (2) between the caffeinated beverage and the control beverage for number of hits, reaction time and false alarm scores. Both caffeinated beverages led to higher physical and mental energy, and lower physical and mental fatigue 60-min post-consumption. These findings suggest beneficial effects on sustained attention through the combination of caffeine with refreshing compounds.
Collapse
|
4
|
Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives. J Sleep Res 2022; 31:e13597. [PMID: 35575450 PMCID: PMC9541543 DOI: 10.1111/jsr.13597] [Citation(s) in RCA: 31] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Accepted: 03/18/2022] [Indexed: 01/11/2023]
Abstract
For hundreds of years, mankind has been influencing its sleep and waking state through the adenosinergic system. For ~100 years now, systematic research has been performed, first started by testing the effects of different dosages of caffeine on sleep and waking behaviour. About 70 years ago, adenosine itself entered the picture as a possible ligand of the receptors where caffeine hooks on as an antagonist to reduce sleepiness. Since the scientific demonstration that this is indeed the case, progress has been fast. Today, adenosine is widely accepted as an endogenous sleep‐regulatory substance. In this review, we discuss the current state of the science in model organisms and humans on the working mechanisms of adenosine and caffeine on sleep. We critically investigate the evidence for a direct involvement in sleep homeostatic mechanisms and whether the effects of caffeine on sleep differ between acute intake and chronic consumption. In addition, we review the more recent evidence that adenosine levels may also influence the functioning of the circadian clock and address the question of whether sleep homeostasis and the circadian clock may interact through adenosinergic signalling. In the final section, we discuss the perspectives of possible clinical applications of the accumulated knowledge over the last century that may improve sleep‐related disorders. We conclude our review by highlighting some open questions that need to be answered, to better understand how adenosine and caffeine exactly regulate and influence sleep.
Collapse
Affiliation(s)
- Carolin Franziska Reichert
- Centre for Chronobiology, University Psychiatric Clinics Basel, Basel, Switzerland.,Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland.,Center for Affective, Stress, and Sleep Disorders, University Psychiatric Clinics Basel, Basel, Switzerland
| | - Tom Deboer
- Laboratory for Neurophysiology, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
| | - Hans-Peter Landolt
- Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.,Sleep & Health Zürich, University Center of Competence, University of Zürich, Zürich, Switzerland
| |
Collapse
|
5
|
Abstract
BACKGROUND: Little independent information on the caffeine content of the popular Nespresso® coffee pod range exists. AIM: To quantify the caffeine content of Nespresso® pod coffees. METHODS: Initially, three serves (ristretto (S), espresso (M), lungo (L)) of two pod varieties (Livanto and Roma) were prepared on three different Nespresso® machines (2 × U-Delonghi (1 × 5 years since purchase (old), 1 × recently purchased (new)), 1 × new Lattissima Pro (alternate)) using two different batches (sleeves). Caffeine content was then determined via triplicate samples using high-performance liquid chromatography. Differences in content (i.e. serve size, machine or sleeve) were determined via an analysis of variance or paired sample t-tests. RESULTS: Coffees prepared on different machines or pods from different sleeves did not influence the caffeine content (old = 63 ± 13, new = 60 ± 8, alternate = 60 ± 10 mg·serve-1; p = 0.537, sleeveA = 63 ± 11, sleeveB = 59 ± 9 mg·serve-1; p = 0.134). Less caffeine was delivered in S (51 ± 7 mg·serve-1) compared to larger sizes (M = 66 ± 7 and L = 66 ± 10 mg·serve-1). Subsequently, the caffeine content from two serve sizes (S and L) from 17 other varieties within the Nespresso® range was determined and compared to the manufacturer's values. Caffeine content (all pods) ranged from 19 to 147 mg·serve-1, and represented 51-162% of manufacturer's values. CONCLUSION: Nespresso® consumers are exposed to variable amounts of caffeine, which often differ from the manufacturer's reports.
Collapse
Affiliation(s)
- Ben Desbrow
- 1 School of Allied Health Sciences, Griffith University, Australia
| | - Susan Hall
- 2 School of Pharmacy and Pharmacology, Griffith University, Australia
| | | |
Collapse
|
6
|
Bioactive Constituents in Caffeinated and Decaffeinated Coffee and Their Effect on the Risk of Depression—A Comparative Constituent Analysis Study. BEVERAGES 2018. [DOI: 10.3390/beverages4040079] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Coffee, a popular beverage throughout the world, has been shown to have numerous beneficial health effects, including reducing the risk of developing depression. This effect has only been shown with the consumption of caffeinated coffee and not decaffeinated coffee or caffeine alone and one of many hypotheses attributes this to the loss of key constituents during the decaffeination process. The aim of this study was to investigate whether any of the key bioactive coffee constituents with known anti-oxidant and anti-inflammatory effects are lost during the decaffeination process. The analysis of nine caffeinated and nine decaffeinated samples of various brands and batches of commonly consumed coffee in Australia using HPLC analysis found that, with the exception of caffeine, there were no significant differences in the quantity of other key bioactive coffee constituents in caffeinated and decaffeinated coffee. These results suggest that there may be an alternative explanation for the observed inverse correlation between caffeinated coffee consumption and the risk of developing depression.
Collapse
|
7
|
Desbrow B, Hall S, O'Connor H, Slater G, Barnes K, Grant G. Caffeine content of pre‐workout supplements commonly used by Australian consumers. Drug Test Anal 2018; 11:523-529. [DOI: 10.1002/dta.2501] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Revised: 09/04/2018] [Accepted: 09/04/2018] [Indexed: 12/17/2022]
Affiliation(s)
- Ben Desbrow
- School of Allied Health SciencesGriffith University Australia
| | - Susan Hall
- School of Pharmacy & PharmacologyGriffith University Australia
| | - Helen O'Connor
- Faculty of Health Sciences and Charles Perkins CentreThe University of Sydney Australia
| | - Gary Slater
- School of Health and Sport SciencesUniversity of the Sunshine Coast Australia
| | - Katelyn Barnes
- School of Allied Health SciencesGriffith University Australia
| | - Gary Grant
- School of Pharmacy & PharmacologyGriffith University Australia
| |
Collapse
|
8
|
Abstract
PURPOSE OF REVIEW Recent evidence documents the negative impact of obesity, diabetes mellitus, and other metabolic dysregulation on neurocognitive function. This review highlights a key dietary factor in these relationships: refined carbohydrates. RECENT FINDINGS Chronic consumption of refined carbohydrates has been linked to relative neurocognitive deficits across the lifespan. Hippocampal function is especially impacted, but prefrontal and mesolimbic reward pathways may also be altered. Early life exposure to refined carbohydrates, (i.e., prenatal, juvenile, and adolescence periods) may be particularly toxic to cognitive functioning. The impact of acute carbohydrate administration is mixed, with some findings showing benefits while others are neutral or negative. Potential mechanisms of the carbohydrate-cognition relationship include dysregulation in metabolic, inflammatory, and vascular factors, whereas moderators include age, genetic factors, physiological (e.g., glucoregulatory) function and the timing and type of carbohydrate exposure. Critically, the negative neurocognitive impacts of diets high in refined carbohydrates have been shown to be independent of total body weight. SUMMARY Neurocognitive deficits induced by a diet high in refined carbohydrates may manifest before overt obesity or metabolic disease onset, suggesting that researchers and providers may need to target subclinical metabolic, inflammatory, and vascular dysregulation factors in efforts to preserve cognitive function across the lifespan.
Collapse
Affiliation(s)
- Misty A W Hawkins
- Department of Psychology, Oklahoma State University, Stillwater, Oklahoma, USA
| | | | | |
Collapse
|
9
|
Altena E, Daviaux Y, Sanz-Arigita E, Bonhomme E, de Sevin É, Micoulaud-Franchi JA, Bioulac S, Philip P. How sleep problems contribute to simulator sickness: Preliminary results from a realistic driving scenario. J Sleep Res 2018; 28:e12677. [PMID: 29664207 DOI: 10.1111/jsr.12677] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Revised: 01/18/2018] [Accepted: 01/18/2018] [Indexed: 12/01/2022]
Abstract
Virtual reality and simulation tools enable us to assess daytime functioning in environments that simulate real life as close as possible. Simulator sickness, however, poses a problem in the application of these tools, and has been related to pre-existing health problems. How sleep problems contribute to simulator sickness has not yet been investigated. In the current study, 20 female chronic insomnia patients and 32 female age-matched controls drove in a driving simulator covering realistic city, country and highway scenes. Fifty percent of the insomnia patients as opposed to 12.5% of controls reported excessive simulator sickness leading to experiment withdrawal. In the remaining participants, patients with insomnia showed overall increased levels of oculomotor symptoms even before driving, while nausea symptoms further increased after driving. These results, as well as the realistic simulation paradigm developed, give more insight on how vestibular and oculomotor functions as well as interoceptive functions are affected in insomnia. Importantly, our results have direct implications for both the actual driving experience and the wider context of deploying simulation techniques to mimic real life functioning, in particular in those professions often exposed to sleep problems.
Collapse
Affiliation(s)
- Ellemarije Altena
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France
| | - Yannick Daviaux
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France
| | | | - Emilien Bonhomme
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France
| | - Étienne de Sevin
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France
| | - Jean-Arthur Micoulaud-Franchi
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.,Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France
| | - Stéphanie Bioulac
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.,Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France
| | - Pierre Philip
- Univ. Bordeaux, SANPSY, USR 3413, F-33000, Bordeaux, France.,CNRS-SANPSY, USR 3413, F-33000, Bordeaux, France.,Clinique du sommeil, CHU Pellegrin, place Amélie-Raba-Léon, 33076, Bordeaux, France
| |
Collapse
|